Neurolytixs’ ground-breaking technologies leverages artificial intelligence to diagnose concussions with blood biomarkers within 48 hours of an incident. Their research has identified a number of blood biomarkers that accurately identify brain injury among patients. This technology is the first test of its kind to yield accuracy in concussion diagnosis.
